Table 1.
Clinical and demographic data of the cohort.
| Parameter | Control | Stroke-COVID | p-Value |
|---|---|---|---|
| Age–mean years (interval) |
70 (42–87) |
72.87 (59–89) |
0.1493 |
| Sex | |||
| M (%) F (%) |
61.1% 38.9% |
42.5% 57.5% |
0.0331 * |
| Comorbidities | |||
| High blood pressure, N (%) | 40 (86.9%) | 48 (96%) | 0.4171 |
| Diabetes mellitus, N (%) | 10 (21.7%) | 13 (26%) | 0.7530 |
| Dyslipidaemia, N (%) | 9 (19.5%) | 28 (56%) | <0.0001 **** |
| Atrial fibrillation, N (%) | 8 (17.3%) | 15 (30%) | 0.0659 |
| Cigarette smoking | |||
| No Yes |
38 (82.60%) 8 (10.86%) |
43 (86%) 7 (6%) |
0.9254 |
| Stroke evaluation | |||
| Right hemisphere, N (%) Left hemisphere, N (%) |
20 (43.47%) 26 (56.52%) |
24 (48%) 26 (52%) |
0.6609 |
| NIHSS evaluation | |||
| 5–15 (Moderate), N (%) 16–20 (Moderate to severe), N (%) |
31 (67.39%) 15 (32.60%) |
38 (76%) 12 (24%) |
0.3539 |
| COVID-19 Severity Scale | |||
| Scores 1, 2 or 3 (Mild) Scores 4 or 5 (Moderate) Scores 6, 7, 8 or 9 (Severe) |
N/A | 17 (34%) 30 (60%) 3 (6%) |
* p < 0.05; **** p < 0.0001; N/A: Not applicable.